EA201690692A1 - Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло - Google Patents

Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло

Info

Publication number
EA201690692A1
EA201690692A1 EA201690692A EA201690692A EA201690692A1 EA 201690692 A1 EA201690692 A1 EA 201690692A1 EA 201690692 A EA201690692 A EA 201690692A EA 201690692 A EA201690692 A EA 201690692A EA 201690692 A1 EA201690692 A1 EA 201690692A1
Authority
EA
Eurasian Patent Office
Prior art keywords
olive oil
acid
stearide
lipid composition
composition containing
Prior art date
Application number
EA201690692A
Other languages
English (en)
Other versions
EA028641B1 (ru
Inventor
Хармен Хофстра
Орьян Саэле
Ола Эльде
Линда Кристин Сага
Original Assignee
Зинзино Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зинзино Аб filed Critical Зинзино Аб
Publication of EA201690692A1 publication Critical patent/EA201690692A1/ru
Publication of EA028641B1 publication Critical patent/EA028641B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)

Abstract

Настоящее изобретение относится к пищевой липидной композиции, содержащей оливковое масло и компонент со стеаридоновой кислотой (компонент с SDA), содержащий большие количества SDA, как, например, по меньшей мере 6 вес.% SDA.
EA201690692A 2013-10-07 2014-10-07 Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло EA028641B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13187560.1 2013-10-07
EP13187560 2013-10-07
PCT/EP2014/071418 WO2015052171A1 (en) 2013-10-07 2014-10-07 Edible lipid composition comprising stearidonic acid and olive oil

Publications (2)

Publication Number Publication Date
EA201690692A1 true EA201690692A1 (ru) 2016-07-29
EA028641B1 EA028641B1 (ru) 2017-12-29

Family

ID=49301375

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690692A EA028641B1 (ru) 2013-10-07 2014-10-07 Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло

Country Status (15)

Country Link
US (1) US20160227808A1 (ru)
EP (1) EP3054777B1 (ru)
JP (1) JP6506746B2 (ru)
KR (1) KR102373207B1 (ru)
CN (1) CN105705025B (ru)
AU (1) AU2014333878B2 (ru)
CA (1) CA2924265C (ru)
DK (1) DK3054777T3 (ru)
EA (1) EA028641B1 (ru)
ES (1) ES2672313T3 (ru)
HU (1) HUE037991T2 (ru)
LT (1) LT3054777T (ru)
NO (1) NO3054777T3 (ru)
PL (1) PL3054777T3 (ru)
WO (1) WO2015052171A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10846257B2 (en) 2014-04-01 2020-11-24 Endance Technology Limited Intelligent load balancing and high speed intelligent network recorders
CN108402466A (zh) * 2017-02-10 2018-08-17 台湾原生药用植物股份有限公司 含不饱和脂肪酸的素食组合物
JP6901274B2 (ja) * 2017-02-14 2021-07-14 株式会社ファンケル ω３系脂肪酸吸収促進用組成物
US11638440B2 (en) * 2017-02-28 2023-05-02 Cg-Bio Genomics, Inc. Healthful supplement food

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150741A1 (en) * 1994-06-17 1995-12-18 Susan Trimbo Pediatric lipid emulsion
KR970705345A (ko) * 1995-07-04 1997-10-09 도리이 신이치로 오메가 6계ㆍ오메가 3계 불포화 지방산의 밸런스 조절제를 배합하여 이루어진 식품 조성물(Food composition containing balancing agent for ω- 6 and ω- 3 unsaturated fatty acids)
JP3466014B2 (ja) * 1995-12-25 2003-11-10 交洋ファインケミカル株式会社 植物性スクワラン濃縮物の製造方法
JP2000104092A (ja) * 1998-09-29 2000-04-11 Nof Corp 血清脂質改善油脂組成物
JP2007056181A (ja) * 2005-08-26 2007-03-08 Toyo Olive Co Ltd 機能性オリーブ油、その製造方法およびその用途
JP4904751B2 (ja) * 2005-09-14 2012-03-28 株式会社カネカ 生体内ｄｈａ合成促進剤
ES2289897B1 (es) * 2005-11-08 2008-12-16 Laboratorios Belmac, S.A. Composicion para administracion transdermica de agentes fisiologicamente activos.
CN101437508A (zh) * 2006-03-03 2009-05-20 孟山都技术有限公司 用于改善心血管健康的十八碳四烯酸
CN101677589A (zh) * 2007-01-03 2010-03-24 孟山都技术有限公司 掺入十八碳四烯酸的食品组合物
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
BRPI1009593A2 (pt) * 2009-06-30 2015-08-18 Solae Llc Composição alimentícia e método de utilização do óleo de soja enriquecido com das"
EP2453766A4 (en) * 2009-07-15 2013-02-13 Solae Llc SOAPS AND SAUCES ENRICHED WITH OMEGA-3 FATTY ACIDS
FR2948025B1 (fr) * 2009-07-15 2013-01-11 Univ Grenoble 1 Composition comprenant un polyphenol et un acide gras omega-3
US8372465B2 (en) * 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
AU2012100994A4 (en) * 2012-06-30 2012-07-26 Hinson, Brian Mr Hempseed/olive oil and waste blending

Also Published As

Publication number Publication date
NO3054777T3 (ru) 2018-08-04
CA2924265A1 (en) 2015-04-16
JP6506746B2 (ja) 2019-04-24
CA2924265C (en) 2019-12-24
AU2014333878B2 (en) 2017-12-07
AU2014333878A1 (en) 2016-04-14
EP3054777A1 (en) 2016-08-17
LT3054777T (lt) 2018-07-10
US20160227808A1 (en) 2016-08-11
JP2016533716A (ja) 2016-11-04
HUE037991T2 (hu) 2018-09-28
EA028641B1 (ru) 2017-12-29
EP3054777B1 (en) 2018-03-07
PL3054777T3 (pl) 2018-10-31
CN105705025A (zh) 2016-06-22
AU2014333878A2 (en) 2016-04-21
KR20160065903A (ko) 2016-06-09
KR102373207B1 (ko) 2022-03-11
CN105705025B (zh) 2020-06-23
DK3054777T3 (en) 2018-06-14
ES2672313T3 (es) 2018-06-13
WO2015052171A1 (en) 2015-04-16

Similar Documents

Publication Publication Date Title
PH12016501151A1 (en) Nrf2 regulators
IN2014DN07322A (ru)
EA202092987A3 (ru) Липид, содержащий докозапентаеновую кислоту
CO7111287A2 (es) Composiciones plaguicidas y procesos relacionados
ZA201908449B (en) Novel modified acid compositions as alternatives to conventional acids in the oil and gas industry
EA201590887A1 (ru) Композиция
WO2014057362A3 (en) Omega -3 compositions
EP3056090A4 (en) Oil/fat composition containing polyunsaturated fatty acid
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
MX2015008766A (es) Compuestos cbd fluorados, composiciones y usos de los mismos.
WO2014140873A3 (en) Omega- 3 phospholipid supplements for improved brain maturity
EP3149105A4 (en) Using synthetic acid compositions as alternatives to conventional acids tn the oil and gas industry
PH12016502050A1 (en) Homovanillinic acid ester, in particular, for creating a hot and/or pungent taste sensation
BR112015023387A2 (pt) composições lipídicas de racecodotril
DK3728509T3 (en) Novel modified acid compositions as alternatives to conventional acids in the oil and gas industry
EA201690793A1 (ru) Способ получения лиофилизированной фармацевтической композиции, содержащей митомицин c
EA201690692A1 (ru) Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло
BR112013018954A2 (pt) utilização de pelo menos um coproduto da indústria de refinação dos óleos vegetais para se obter um insaponificável total purificado de óleo vegetal.
EA201690856A1 (ru) Применение жирной кислоты таллового масла в связывании токсинов
MX349987B (es) Emulsión orgánica que comprende dha y epa.
EA201500927A1 (ru) Твердые липидные наночастицы (i)
EA201591725A1 (ru) Твердые липидные наночастицы (ii)
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
BR112016006281A2 (pt) formulações líquidas transparentes e bebidas transparentes contendo as mesmas
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG TJ TM